
GRL Pharma Private Limited
About GRL Pharma Private Limited
Data last updated:
GRL Pharma Private Limited is a private limited company based in Thrissur, Kerala, India. It was incorporated on 20 October 2023.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U46497KL2023PTC084158.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mangalam Krishnan Sachidanandan and Mundangattil Rahul Raju (Individual Subscriber).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 8/520 – 5 Pck Building, Vilvattam Nellikkad Thrissur, Kerala, India – 680631.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.09 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹15.92 Lakh (net margin -7.6%) and EBITDA of -₹14.06 Lakh (EBITDA margin -6.7%).
Company details
Contact details
GRL Pharma Private Limited's registered office is in Thrissur, Kerala.
- Registered AddressRoom No. 8/520 – 5 Pck Building, Vilvattam Nellikkad Thrissur, Kerala, India – 680631
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of GRL Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of GRL Pharma Private Limited, buy the company report.
Financials of GRL Pharma Private Limited
FY 2025 filings availableGRL Pharma Private Limited reported revenue of ₹2.09 Cr (up 350% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 350% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹14.06 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹15.92 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -6.7% | |
| Net Profit Margin | -7.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of GRL Pharma Private Limited, buy the company report.
Board of directors of GRL Pharma Private Limited
GRL Pharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mangalam Krishnan Sachidanandan | Director | 20 Oct 2023 | 3 Years 1 Months | Current |
| Mundangattil Rahul Raju | Individual Subscriber | 20 Oct 2023 | 3 Years 1 Months | Current |
| Binu Kozhimannil Mathew | Individual Subscriber | 20 Oct 2023 | 3 Years 1 Months | Current |
| Chandrasekharan Hemalatha Anush | Individual Subscriber | 20 Oct 2023 | 3 Years 1 Months | Current |
Peer comparison
GRL Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediere Pharmaceuticals Private Limited | ₹2.1 Cr (FY 2024) | Nahan, Himachal Pradesh, India | ||||
| Spycaa Life Care Sciences Private Limited | ₹2.1 Cr (FY 2024) | 14.0% | Maduranthakam, Tamil Nadu, India | |||
| GRL Pharma Private Limitedthis company | ₹2.09 Cr (FY 2025) | -₹15.92 Lakh | -7.6% | 350.0% | Thrissur, Kerala, India | |
| Zydus Technologies Limited | ₹2.09 Cr (FY 2019) | Ahmedabad, Gujarat, India |
To see the full peer comparison of GRL Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving GRL Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GRL Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for GRL Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
GRL Pharma Private Limited has 8 board changes on record since 2023: 4 appointments and 4 cessations. The latest: Binu Kozhimannil Mathew ceased to be Additional Director on 30 Dec 2024.
Frequently asked questions
GRL Pharma is an active private limited company based in Thrissur, Kerala, India. It was incorporated on 20 October 2023 (3+ years old) and is registered under CIN U46497KL2023PTC084158.
GRL Pharma has 4 current directors:
- Mangalam Krishnan Sachidanandan - Director
- Mundangattil Rahul Raju - Individual Subscriber
- Binu Kozhimannil Mathew - Individual Subscriber
- Chandrasekharan Hemalatha Anush - Individual Subscriber
The latest financial statements of GRL Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of GRL Pharma is U46497KL2023PTC084158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GRL Pharma was incorporated on 20 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of GRL Pharma by revenue are Mediere Pharmaceuticals Private Limited, Spycaa Life Care Sciences Private Limited, Zydus Technologies Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Binu Kozhimannil Mathew ceased to be Additional Director on 30 Dec 2024. Chandrasekharan Hemalatha Anush ceased to be Additional Director on 30 Dec 2024. Mundangattil Rahul Raju ceased to be Additional Director on 30 Dec 2024. GRL Pharma has 8 board changes on record in total.
The registered office of GRL Pharma is at Room No. 8520 – 5 Pck Building, Vilvattam Nellikkad Thrissur, Kerala, India – 680631.
GRL Pharma can be reached at its registered office: Room No. 8520 – 5 Pck Building, Vilvattam Nellikkad Thrissur, Kerala, India – 680631.
GRL Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Ernakulam.

